Kyverna Therapeutics (NASDAQ:KYTX) Posts Quarterly Earnings Results, Misses Expectations By $0.28 EPS

Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) announced its earnings results on Tuesday. The company reported ($1.12) earnings per share for the quarter, missing the consensus estimate of ($0.84) by ($0.28), Briefing.com reports. During the same period in the previous year, the firm posted ($12.10) earnings per share. Kyverna Therapeutics Trading Up 2.4 % Kyverna […]

Related Keywords

Leerink Partnrs ,Jpmorgan Chase Co ,Wells Fargo Company ,Kyverna Therapeutics Inc ,Kyverna Therapeutics Company Profile ,Morgan Stanley ,Kyverna Therapeutics ,Get Free Report ,Kyverna Therapeutics Daily ,